🇺🇸 FDA
Patent

US 11547101

Non-human animals having a disruption in a C9ORF72 locus

granted A61KA61K49/0008A61P

Quick answer

US patent 11547101 (Non-human animals having a disruption in a C9ORF72 locus) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K49/0008, A61P, A61P25/28, A61P29/00